Tuberculous patients in Respiratory Intensive Care Unit: Characteristics and Outcome

Mohamed Mohamed Nabil Ibrahim;

Abstract


Tuberculosis (TB) remains a major health problem worldwide. TB affects

10 million people each year and is one of the top ten causes of death for the past 5 years. In 2015, WHO estimated 1.4 million TB-related deaths with an addition of
0.4 million deaths resulting from TB/HIV co-infection. Multidrug-resistant TB (MDRTB) (clinically defined as TB resistance to at least isoniazid and rifampicin) is a high burden TB variant which is progressively emerging due to improper management of TB (e.g. lack of adherence to medications), or person-to-person transmission (Duro RP et al, 2017). WHO recently reported 480,000 new cases of MDRTB in addition to 100,000 new cases of rifampicin-resistant TB (RR-TB) who are at risk to develop MDRTB (WHO, 2017).

In 1990, the WHO estimated the prevalence and incidence of tuberculosis in Egypt to be 82/100,000 and 35/100.00, respectively. Effective diagnosis and treatment reduced TB prevalence and incidence in 2015 to 27 /100,000 and 15 /
100.00 cases population (a half of the 1990 estimate) (Egyptian Guidelines,

2017).


Other data

Title Tuberculous patients in Respiratory Intensive Care Unit: Characteristics and Outcome
Other Titles مرضى الدرن فى وحدة الرعاية المركزة للجهاز التنفسي : محددات ونتائج
Authors Mohamed Mohamed Nabil Ibrahim
Issue Date 2020

Attached Files

File SizeFormat
BB2306.pdf2.2 MBAdobe PDFView/Open
Recommend this item

Similar Items from Core Recommender Database

Google ScholarTM

Check

views 3 in Shams Scholar


Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.